|
FKTN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.653200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.477600E-02 |
| Normal-vs-Stage2 |
5.214600E-01 |
| Normal-vs-Stage3 |
5.128100E-02 |
| Normal-vs-Stage4 |
4.437700E-03 |
| Stage1-vs-Stage2 |
6.616000E-01 |
| Stage1-vs-Stage3 |
8.19950000000569E-05 |
| Stage1-vs-Stage4 |
2.97969999996095E-06 |
| Stage2-vs-Stage3 |
5.901600E-02 |
| Stage2-vs-Stage4 |
1.115530E-02 |
| Stage3-vs-Stage4 |
2.790000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.213000E-01 |
| Normal-vs-AfricanAmerican |
7.356400E-02 |
| Normal-vs-Asian |
6.057200E-01 |
| Caucasian-vs-AfricanAmerican |
2.750300E-02 |
| Caucasian-vs-Asian |
7.494200E-01 |
| AfricanAmerican-vs-Asian |
2.171800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.588400E-01 |
| Normal-vs-Female |
2.775400E-01 |
| Male-vs-Female |
3.129700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.492400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.326200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.089600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.809000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.445800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.508800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.911800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.710010E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.820000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.340600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.124600E-03 |
| Normal-vs-Grade 2 |
2.669800E-02 |
| Normal-vs-Grade 3 |
2.225600E-01 |
| Normal-vs-Grade 4 |
1.030510E-04 |
| Grade 1-vs-Grade 2 |
2.560400E-01 |
| Grade 1-vs-Grade 3 |
1.682680E-03 |
| Grade 1-vs-Grade 4 |
2.41460000000027E-05 |
| Grade 2-vs-Grade 3 |
5.54689999999747E-05 |
| Grade 2-vs-Grade 4 |
1.89899995728382E-09 |
| Grade 3-vs-Grade 4 |
6.778400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.991570E-04 |
| Normal-vs-ccB subtype |
2.965700E-02 |
| ccA subtype-vs-ccB subtype |
2.17910134381327E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.149400E-01 |
| Normal-vs-N1 |
1.372830E-01 |
| N0-vs-N1 |
1.612450E-01 |
|
|
